By www.reliablemarketinsights.com
Global T Cell Antigen Gp39 Market Research Report 2023 Story
85
$ 2900
T Cell Antigen Gp39 Report report is categorised based on following features:
1. Global Market Players
2. Geopolitical regions
3. Consumer Insights
4. Technological advancement
5. Historic and Future Analysis of the Market
Biogen, Inc. Bristol-Myers Squibb Company eTheRNA Immunotherapies NV ImmuNext, Inc. Juno Therapeutics Inc. MedImmune, LLC Targovax AS XL-protein GmbH